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During Tissue Preparation for
Scanning Electron Microscopy
In a recent study, Silvain et al. (1) evaluated extracted thrombi
obtained by thromboaspiration in 44 samples from consecutive
patients with ST-segment elevation myocardial infarction using
scanning electron microscopy. Also, various plasma biomarkers
(troponin I, ultrasensitive C-reactive protein, interleukin-6,
plasminogen activator inhibitor-1, soluble CD40 ligand, and
tumor necrosis factor-alpha) and plasma fibrin clot viscoelastic
properties were measured in peripheral blood. Coronary
thrombi were composed mainly of fibrin (55.9  18%), with
platelets (16.8  18%), erythrocytes (11.5  9%), cholesterol
rystals (5.2  8.4%), and leukocytes (1.3  2.0%). Also, the
nvestigators demonstrated that fibrin content increased with
schemia duration and that ischemic time was the primary
redictor of thrombus composition, with a 2-fold increase of
brin content per ischemic hour.
The study was well performed, using high-resolution scan-
ing electron microscopic techniques. However, the use of
ehydrating agents, such as ethanol, during tissue preparation
or scanning electron microscopy, as referenced by Silvain et al.
1), can readily dissolve cholesterol crystals, thus greatly atten-
ating their presence and extent. We had previously reported in
1 cases that cholesterol crystals constitute a great amount of
he extracted atherothrombotic aspirates during acute myocar-
ial infarction (2). In addition to high density of crystals in
hese samples, their size was large enough to potentially
bstruct medium-size coronary arteries. This discrepancy in the
mount of cholesterol crystals detected between these studies is
robably related to the tissue preparation methods. We have
emonstrated that ethanol can readily dissolve cholesterol
rystals in human plaques removed at autopsy as well as during
arotid endarterectomy (3). When comparing the same arterial
laque whereby one-half the specimen was prepared with
thanol versus vacuum dehydration, almost all crystals were
issolved and barely identified on scanning electron microscopy
fter ethanol compared with vacuum dehydration. This may
elp explain the relatively small amount of cholesterol crystals
etected by Silvain et al. (1).
George S. Abela, MD, MSc
adi Shamoun, MD
meeth Vedre, MD
orothy R. Pathak, PhD
brahim Shah, MD
aurav Dhar, MD
ale Leffler, DOMichigan State University
epartment of Medicine
ivision of Cardiology
208 Clinical Center
ast Lansing, Michigan 48824
-mail: george.abela@ht.msu.edu
doi:10.1016/j.jacc.2011.08.065
EFERENCES
1. Silvain J, Collet J-P, Nagaswami C, et al. Composition of coronary
thrombus in acute myocardial infarction. J Am Coll Cardiol 2011;57:
1359–67.
2. Abela GS, Shamoun F, Vedre A, et al. Extent of cholesterol crystals in
coronary artery aspirates during acute myocardial infarction. J Am Coll
Cardiol 2010;55 Suppl:E1019.
3. Abela GS, Aziz K, Vedre A, Pathak D, Talbott JD, DeJong J. Effect of
cholesterol crystals on plaques and intima in arteries of patients with acute
coronary and cerebrovascular syndromes. Am J Cardiol 2009;103:959–68.
Reply
Dr. Abela and colleagues correctly point out that the use of
ethanol, a dehydrating agent, in the preparation of the coronary
thrombi samples for scanning electron microscopy may have
dissolved cholesterol crystals and led to an underestimation of the
true content of cholesterol crystals in the coronary thrombi
retrieved by thromboaspiration.
The study by Abela et al. (1) demonstrated that the use of vacuum
dehydration of tissues is likely the preferred technique to study the
impact of cholesterol crystals on biological membranes in vitro. In our
study (2), we focused on the 2 main pharmacological therapeutic
targets in acute coronary syndromes that can be visualized by micros-
copy, platelets, and fibrin fibers. Therefore, we preferred to use the
ethanol dehydration technique instead of vacuum dehydration, to
avoid the shrinkage and distortion of fibrin fibers that can occur with
the latter technique. It was important to understand how the coronary
thrombi evolve in time to understand the usefulness of treatments,
such as fast-acting P2Y12 inhibitors or glycoprotein IIb/IIIa inhibi-
tors, and their optimal use in the time course of the event.
However, the hypothesis of cholesterol crystals perforating the
intima and being the underlying mechanism of plaque rupture is
seductive and deserves more in vivo studies. Unfortunately, no
currently available technology can detect cholesterols crystals in
vivo in patients experiencing acute coronary syndromes, and even
though angioscopy has been used to define thrombus colors, the
lack of magnification and 3-dimensional analysis as provided by
scanning electron microscopy does not allow the identification of
such small structures (3).
Finally, it must be considered that the thromboaspiration
technique does not allow a transversal analysis from 1 side of the
artery to the other, as done in histological analysis of postmortem
coronary arteries, but is most likely to retrieve a piece of the
thrombus in the inner lumen, distant from the site of plaque
rupture and therefore with fewer cholesterol crystals. This differ-
ence, added to the possibility of cutting-induced translocation of
cholesterol crystals from the plaque itself to the inner lumen during
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the amount of cholesterol crystals found in our study.
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